Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules
-
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County
-
Liftology Launches National Franchise System to Redefine Home Accessibility Through Dignity and Freedom
-
IsoEnergy Announces the Appointment of Nathan Bridge as Vice President, Exploration and Dr. Dan Brisbin as Vice President, Geology
-
Upbound Group, Inc. Announces Timing of Third Quarter 2026 Financial Results
-
Poplin Launches On-Demand Shoe Cleaning Service
-
United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting
-
Capture6 Launches Project Tortuga in Western Australia, Demonstrating Scalable Water Recovery and Carbon Removal
-
Graywind Arched & Angled Shades Bring Smart Shading to the Industry's Most Challenging Window Shapes
-
Opus Genetics to Present at the Chardan Annual Healthcare Conference
-
Oracle RMS Appoints Shawn LaPalm as Vice President, Specialty Program Development
-
Appficiency Announces Strategic Growth Investment in RedPoint Solutions
-
Darcy Partners Acquires Realize 2050; Forms Dedicated Power & Utilities Business Unit
-
Formentera Partners Announces Jay R. Pryor Joins as Operating Partner
-
Quantum XChange CEO to Lead Post-Quantum Cryptography Panel at ACT-IAC 2026 Cyber Summit
-
Central Georgia EMC and Base Power Launch Residential Battery Program to Bring Affordable Whole-Home Backup to Georgia
-
Ouster Announces Date for Third Quarter 2026 Earnings Call
-
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
-
HUUCH BOX, an AI-Powered Full-Body Motion Game Box, Launches in the U.S. On October 15
-
Bowhead Specialty to Announce Third Quarter 2026 Earnings on November 3, 2026
-
Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update
-
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at AS
-
First Atlantic Nickel & Cobalt Drills First Discovery Hole at Alloy Max South Zone with Drill Hole XL-26-18: Best Near-Surface Visible Awaruite to Date at Alloy Max, Ending in Open Mineralization; XL-
-
Origin Agritech Receives Full US$2.8 Million from Previously Announced Private Placement at US$1.40 Per Share
-
New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP
-
Tyton Partners Promotes Brian Feeney to Managing Director
-
Electra Signs Term Sheet for Strategic Partnership with Global Commodities Trader WMC
-
Ollie’s Bargain Outlet Holdings, Inc. Announces $500 Million Share Repurchase Authorization
-
Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual Congress
-
Talen Energy to Report Third Quarter 2026 Financial Results on November 3, 2026
-
Duncan Aviation orders 40 Gogo Galileo HDX systems, responding to customer demand
-
Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update
-
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
-
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
-
ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams
-
Highlander Silver Welcomed by President Keiko Fujimori of Peru
-
Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156
-
Sitryx Reports Positive Phase 1b Results for First-in-Class Oral PKM2 Modulator SYX-5219 in Patients with Moderate to Severe Atopic Dermatitis
-
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress
-
INEO Reports 47% Fiscal 2026 Revenue Growth as Q4 Revenue Reaches Record $1.03 Million
-
Garmin marks 1,000th King Air retrofit with G1000 integrated flight deck delivered to the U.S. Army
-
Northisle Announces Exploration and Geology Team Transition Plan
-
Priceline Reveals 2027 "Where to Next?" Travel Trends Report as Americans Find New Ways to Make Every Trip Count
-
JAGUAR URANIUM ANNOUNCES MAIDEN MINERAL RESOURCE ESTIMATE AT LAGUNA SALADA IN ARGENTINA
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Quanta Services Announces Third Quarter 2026 Earnings Release & Webcast Schedule
-
SentinelOne Announces Proposed Private Placement of $1.25 Billion of Convertible Senior Notes Due 2031
-
Ryder Ranks Among Top Companies for Women to Work in Trucking
-
CoTec Holdings Corp. Notes EU Strategic Project Designation for HyproMag GmbH
-
Foresight Signed a Non-Binding Term Sheet to Acquire 50.01% in a 270MW Capacity European Data Center Development Company
